ALX1-11 recombinant human parathyroid hormone: Will start in April a 12-month Phase II trial at three dose levels and placebo, to test ALX1-11's efficacy in cha

By WIR Staff | Mar 20, 1995 | 8:00 AM GMT

Allelix Biopharmaceuticals Inc. (AXB), Toronto

Read the full 57 word article

How to gain access

Continue reading with a
two-week free trial.